Cocrystal Pharma Inc.

NASDAQ: COCP · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.72
1.11%
After-hours: Aug 15, 2025, 04:31 PM EDT

Cocrystal Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-17.5M -17.98M -38.84M -14.19M
Depreciation & Amortization
126K -1.39M 388K 190K
Stock-Based Compensation
643K 801K 855K 724K
Other Working Capital
1.36M 296K -2.39M 240K
Other Non-Cash Items
250K 1.56M 18.87M -195K
Deferred Income Tax
n/a n/a n/a -49K
Change in Working Capital
140K 2.34M -2.71M 796K
Operating Cash Flow
-16.48M -14.67M -21.43M -12.72M
Capital Expenditures
-8K -118K -74K -52K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-8K -118K -74K -52K
Debt Repayment
n/a -7K -27K -39K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
n/a 3.99M -27K 38.47M
Net Cash Flow
-16.49M -10.79M -21.54M 25.7M
Free Cash Flow
-16.49M -14.78M -21.51M -12.77M